You are here: HomeNewsHealth2021 12 10Article 504937

Health News of Friday, 10 December 2021


US coronavirus vaccine donations to Nigeria rises to 13.5m doses

Coronavirus vaccine Coronavirus vaccine

The United States Coronavirus vaccine donation has risen to 13.5 million doses to Nigeria as 2.5 million Pfizer vaccine arrived the country this week.

To date, the United States has donated more than 13.5 million doses of Coronavirus vaccine in partnership with COVAX, or bilaterally to Nigeria.

Additionally, the United States has provided more than $119 million in Coronavirus related health assistance.

This includes a 40-bed mobile field hospital, ventilators and related training for 88 hospitals, personal protective equipment, technical assistance for vaccine readiness, risk communication and demand generation for vaccines, conducting an epidemiological Coronavirus detection and vaccine hesitancy survey, setting up electronic record systems, rapid response teams, training for over 200,000 military and civilian personnel on Coronavirus control measures, and technology for virtual training.

In addition, the United States leveraged the PEPFAR-supported National Integrated Specimen Referral Network (NiSRN) and laboratory investments to support expansion of the NCDC (153) molecular laboratory network nationwide.

A statement by the U.S. Embassy in Nigeria said that the arrival of 2.5 million Pfizer vaccine doses in Abuja this week is proudly welcomed

It added that the National Primary Health Care Development Agency received the vaccines, ensuring they were taken to cold storage to prepare for distribution to over 3,000 health facilities across all 36 states and FCT-Abuja, revealing that over the next several weeks, the vaccines will be available at major markets, shopping malls, event centers, motor parks, airports, places of employment, and religious institutions as part of Nigeria’s mass vaccination campaign.

The United States has said that it is committed to donating more than one billion vaccine doses around the world, by early 2022.

This includes in African countries primarily through the COVAX initiative, improving equitable distribution remains a priority for the United States to prevent the emergence of new variants that threaten populations everywhere.